Trial · NCT07244003
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The change of HbA1c compared to the baseline | from baseline to week 24 | |
| Secondary | The proportion of participants achieving HbA1c, blood pressure, and cholesterol targets | week 24 | HbA1c ≤ 7.0% Blood pressure \< 130/80 mmHg For subjects without ASCVD, LDL-C \< 2.6 mmol/L; for subjects with ASCVD, LDL-C \< 1.8 mmol/L (\< 70 mg/dL) |
| Secondary | The proportion of patients achieving HbA1c target without hypoglycemia or weight gainning | week 24 | HbA1c target ≤ 7.0% The definition of hypoglycemia is: Blood glucose \< 70 mg/dL ( \< 3.9 mmol/L), regardless of whether there are symptoms of hypoglycemia. |
| Secondary | The changes of waist circumference and hip circumference compared to the baseline | from baseline to week 24 | |
| Secondary | The changes of fasting blood glucose, 2-hour post-meal blood glucose, fasting glucagon, fasting insulin, insulin resistance index (HOMA-IR) compared to the baseline | from baseline to week 24 | |
| Secondary | Changes in systolic and diastolic blood pressure compared to the baseline | from baseline to week 24 | |
| Secondary | The changes in urine albumin-to-creatinine ratio (UACR) compared to the baseline | from baseline to week 24 | |
| Secondary | The changes of body mass compared to the baseline | from baseline to 24 week | |
| Secondary | The changes of BMI compared to the baseline | from baseline to 24 week | |
| Secondary | The changes of waist-hip ratio, waist-to-height ratio compared to the baseline | from baseline to 24 week | |
| Other | The changes in total cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, alanine aminotransferase, and aspartate aminotransferase compared to the baseline | from baseline to week 120 | |
| Other | The proportion of participants who received rescue treatment | from baseline to week 24 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07244003/registered